Skip to main content

XR 300 (Quetiapine Fumarate Extended-Release 300 mg)

Pill with imprint XR 300 is Yellow, Capsule-shape and has been identified as Quetiapine Fumarate Extended-Release 300 mg. It is supplied by AstraZeneca Pharmaceuticals LP.

Quetiapine is used in the treatment of bipolar disorder; schizoaffective disorder; schizophrenia; depression; major depressive disorder and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Quetiapine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for XR 300

Quetiapine Fumarate Extended-Release

XR 300
300 mg
19.00 mm
Prescription only
Drug Class
Atypical antipsychotics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
AstraZeneca Pharmaceuticals LP
National Drug Code (NDC)
00310-8283 (Discontinued)
Inactive Ingredients
lactose monohydrate, microcrystalline cellulose, hypromelloses, polyethylene glycol 400, titanium dioxide, ferric oxide yellow, magnesium stearate, water

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "XR 300"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.